Home » Services » Preclinical studies » Efficacy studies » Diabetic retinopathy
Diabetic retinopathy

Models:

  • retinal vascular permeability: VEGF-induced fluorescein leakage
  • retinal angiogenesis / retinopathy of prematurity (ROP): animal model of oxygen-induced retinopathy (OIR)

 

Administration: topical ocular administration, i.v., i.p.

 

Animals: albino or pigmented rats, rabbits, mice

 

Evaluation:

  • Glycemia
  • Histology
  • Fluorescein permeation (fluotron)

Reference substances: corticoids

 

If you need more information on others Iris Pharma’s animal models of Diabetic Retinopathy, please contact us at info@iris-pharma.com or call 33 4 93 59 49 59